2016
DOI: 10.1515/jim-2016-0058
|View full text |Cite
|
Sign up to set email alerts
|

Double Autologous Stem Cell Transplantation in a Case of Non-secretory Multiple Myeloma

Abstract: Multiple myeloma represents a challenge for hematologists because it has become more frequent at a young age in recent years. This is why autologous stem cell transplantation is included in the standard treatment of myeloma patients. We present the case of a 39-year-old patient who was diagnosed with non-secretory myeloma with double autologous transplantation and underwent neurosurgery for spinal cord compression caused by a plasmocytoma at D5 level. We present the evolution and complexity of this very diffic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 6 publications
0
1
0
Order By: Relevance
“…2,7 A second transplantation is recommended if the patient did not reach complete remission or very good partial remission (VGPR), or relapses in less than 12 months after the first transplantation. 19 The conditioning regimens can be performed with melphalan 140 mg/m 2 combined with total body irradiation or melphalan 200 mg/m 2 . 5 In the Clinic of Hematology and Transplant of Tîrgu Mureș, the conditioning treatment is performed only with melphalan, without irradiation.…”
Section: Autologous Stem Cell Transplantationmentioning
confidence: 99%
“…2,7 A second transplantation is recommended if the patient did not reach complete remission or very good partial remission (VGPR), or relapses in less than 12 months after the first transplantation. 19 The conditioning regimens can be performed with melphalan 140 mg/m 2 combined with total body irradiation or melphalan 200 mg/m 2 . 5 In the Clinic of Hematology and Transplant of Tîrgu Mureș, the conditioning treatment is performed only with melphalan, without irradiation.…”
Section: Autologous Stem Cell Transplantationmentioning
confidence: 99%